TJ Biotech Holding ApS: Financial statements 2024
CVR: 41953616
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
TJ Biotech Holding ApS (CVR 41953616) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 118,224 and a net result of DKK 667,738 compared with DKK -9,513,527 the year before. That is an increase of 68.9% compared with the year before. Equity in the 2024 report amounted to DKK 14,422,569. The solvency ratio was 76.1%.
- Gross Profit
- DKK 118,224
- Profit/Loss
- DKK 667,738
- Equity
- DKK 14,422,569
- Total Assets
- DKK 18,946,851
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 118K | 668K | 14.4M | 0 |
| 2023 | - | 70K | -9.5M | 13.8M | 0 |
| 2022 | - | 54K | -216K | 23.3M | 0 |
| 2021 | - | 1.7M | 413K | 23.5M | 1 |
| 2020 | - | 1.4M | 90K | 23.1M | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
TJ Biotech Holding ApS has published its annual report for 2023. Gross profit came to DKK 70,004, and the net result was DKK -9,513,527.
About TJ Biotech Holding ApS
TJ Biotech Holding ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2020. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Engelbrecht Nordkild Jonassen. The company is owned by Thomas Engelbrecht Nordkild Jonassen. The company has 1 employee (2021). In 2025, the company reported a gross profit of DKK 70,424 and a net result of DKK 4,184,576 compared with DKK 667,738 the year before. Equity in the 2025 report amounted to DKK 18,607,145.
